Table 2.
Univariate and multivariate analyses for predictors of overall survival
| Vriables | Overall survival | |||||
|---|---|---|---|---|---|---|
| Univariate analysis | Multivariate analysis | |||||
| HR | 95%CI | P value | HR | 95%CI | P value | |
| Age (<60 vs ≥60) | 1.574 | 0.779-3.178 | 0.206 | |||
| Gender (male vs female) | 0.731 | 0.371-1.440 | 0.365 | |||
| Lymph node metastasis (no vs yes) | 5.004 | 2.258-11.087 | <0.001 | 10.933 | 4.133-14.481 | 0.027 |
| TNM stage (I/II vs III/IV) | 3.812 | 1.783-8.147 | 0.001 | |||
| Differentiation (well vs moderate/poor) | 7.726 | 2.644-22.582 | <0.001 | 8.368 | 2.403-29.145 | 0.001 |
| aPKCɩ expression (low vs high) | 4.329 | 2.000-9.368 | <0.001 | 4.766 | 1.549-14.661 | 0.006 |
| CD68 expression (low vs high) | 2.529 | 1.094-5.844 | 0.030 | |||
| CD80 expression (low vs high) | 1.272 | 0.646-2.503 | 0.486 | |||
| CD206 expression (low vs high) | 5.981 | 2.567-13.936 | <0.001 | 3.526 | 1.268-9.808 | 0.016 |
HR hazard ratio, CI confidence interval